Business Terms
NHS, Genomics PLC to Integrate Polygenic Risk Scores With Traditional Cardiovascular Risk Factors
A newly launched pilot study aims to demonstrate the effectiveness of genetic risk assessment in preventing cardiovascular disease in England.
Canary Molecular POC SARS-CoV-2 Test Nabs CE Mark
The molecular point-of-care test uses biosensors and cloud-based analytics to deliver results within 20 minutes.
Sema4 to Acquire GeneDx for $623M
While GeneDx parent Opko Health is essentially exiting the MDx business, it will pick up a "significant" stake in Sema4.
Nightingale Health to Acquire Genetic Testing Firm Negen
Through the acquisition, Nightingale intends to combine its metabolite-based blood test with genomic data to improve early disease risk detection.
Seegene Multiplex COVID-19/Flu/RSV Test Receives Health Canada Approval
The PCR-based syndromic test distinguishes among four respiratory viruses, and the company has delivered 340,000 of the tests to Canada so far.
Jan 13, 2022
Jan 13, 2022
Quanterix Projects Q4 2021 Revenues of $29M to $31M
Jan 13, 2022
Interpace Commences $30M Rights Offering
Jan 12, 2022
Chronus Health Closes $22M Series A Financing Round
Jan 11, 2022
Jan 11, 2022